HEALTH AND ENVIRONMENT ALLIANCE

Their core work

HEAL is a Brussels-based NGO that bridges environmental science and public health policy across Europe. They specialize in translating research findings on environmental pollutants, climate-related health risks, and chemical exposures into actionable policy recommendations for EU decision-makers. Their core contribution to research consortia is knowledge translation — turning complex scientific outputs into evidence that policymakers, health professionals, and affected communities can use. They work across the chain from exposome research and human biomonitoring to climate-health impacts on vulnerable populations.

What they specialise in

How they've shifted over time

HEAL's H2020 activity spans 2019–2021 (project start dates), a relatively compressed window. Their earlier projects (HERA, ATHLETE) centered on integrating environment-health research and understanding early-life exposome — how chemical pollutants affect pregnancy and child development. Their more recent entries (ENBEL, POLYRISK) show a clear pivot toward climate-driven health threats (heat stress, wildfires, air pollution) and emerging contaminants like micro- and nanoplastics, reflecting the broader EU policy shift toward Green Deal priorities.

HEAL is moving from chemical exposure science toward the intersection of climate change and public health, positioning them as a policy partner for Green Deal–aligned health research.

How they like to work

HEAL operates exclusively as a participant, never as coordinator — consistent with their role as a policy advocacy and knowledge translation organization rather than a research-performing institution. They work in large consortia (71 unique partners across 27 countries), suggesting they are valued as a dissemination and policy interface node rather than a technical research contributor. Their broad partner network indicates they are a connector organization, linking research communities to policy audiences.

HEAL has collaborated with 71 unique partners across 27 countries, giving them one of the broadest geographic networks relative to their project count. Their Brussels base and pan-European reach make them a natural bridge between research consortia and EU-level policy institutions.

What sets them apart

HEAL occupies a distinctive niche as an environmental health advocacy NGO inside research consortia — they are not a lab or university, but the organization that ensures research findings reach policymakers and the public. For consortium builders, HEAL brings ready-made connections to EU health and environment policy circles, plus proven experience in knowledge translation and health impact assessment. Their dual focus on chemical pollutants and climate-health makes them relevant to both traditional toxicology projects and the growing climate adaptation research space.

Highlights from their portfolio

• ATHLETE
  Largest project by HEAL's share (EUR 312,500), focused on the full lifecourse exposome — from pregnancy through adolescence — with strong FAIR data and intervention components.
• POLYRISK
  Addresses the rapidly growing policy concern of micro- and nanoplastic health risks, combining exposure science with immunotoxicity and real-life case studies.
• ENBEL
  Directly targets EU policy-making on climate change and health, bridging Belmont Forum research with European policy needs including LMIC perspectives.